Aviva PLC Illumina, Inc. Transaction History

Aviva PLC

$36.8 Billion
Q3 2024

A detailed history of Aviva PLC transactions in Illumina, Inc. stock. As of the latest transaction made, Aviva PLC holds 56,882 shares of ILMN stock, worth $7.97 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

56,882

Previous 56,221 1.18%

Holding current value

$7.97 Million

Previous $5.87 Million 26.4%

% of portfolio

0.02%

Previous 0.02%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$105.28 - $135.9 $69,590 - $89,829	661 Added 1.18%	56,882 $7.42 Million
Q2 2024 Aug 02, 2024	SELL	$101.05 - $133.57 $6.32 Million - $8.36 Million	-62,586 Reduced 52.68%	56,221 $5.87 Million
Q1 2024 May 14, 2024	SELL	$127.73 - $147.2 $2.65 Million - $3.05 Million	-20,733 Reduced 14.86%	118,807 $16.3 Million
Q4 2023 Feb 09, 2024	BUY	$92.79 - $142.53 $7.02 Million - $10.8 Million	75,602 Added 118.24%	139,540 $19.4 Million
Q3 2023 Nov 13, 2023	SELL	$128.91 - $192.44 $8.47 Million - $12.7 Million	-65,742 Reduced 50.7%	63,938 $8.78 Million
Q2 2023 Aug 10, 2023	BUY	$183.43 - $232.67 $22.7 Million - $28.8 Million	123,677 Added 2060.25%	129,680 $24.3 Million
Q1 2023 May 12, 2023	SELL	$193.75 - $232.55 $6.78 Million - $8.14 Million	-35,000 Reduced 85.36%	6,003 $1.4 Million
Q4 2022 Feb 09, 2023	BUY	$187.24 - $242.74 $2.2 Million - $2.85 Million	11,753 Added 40.18%	41,003 $8.29 Million
Q3 2022 Nov 14, 2022	BUY	$177.23 - $227.44 $453,708 - $582,246	2,560 Added 9.59%	29,250 $5.58 Million
Q2 2022 Aug 04, 2022	SELL	$181.58 - $368.0 $3.09 Million - $6.27 Million	-17,032 Reduced 38.96%	26,690 $4.92 Million
Q1 2022 May 13, 2022	SELL	$303.87 - $423.8 $326,964 - $456,008	-1,076 Reduced 2.4%	43,722 $15.3 Million
Q4 2021 Feb 10, 2022	SELL	$347.28 - $421.83 $3.38 Million - $4.1 Million	-9,722 Reduced 17.83%	44,798 $17 Million
Q3 2021 Nov 12, 2021	BUY	$405.61 - $524.84 $2.19 Million - $2.83 Million	5,401 Added 11.0%	54,520 $22.1 Million
Q2 2021 Aug 10, 2021	BUY	$372.84 - $481.5 $17,896 - $23,112	48 Added 0.1%	49,119 $23.2 Million
Q1 2021 May 13, 2021	SELL	$361.28 - $504.76 $136,563 - $190,799	-378 Reduced 0.76%	49,071 $18.8 Million
Q4 2020 Feb 10, 2021	BUY	$292.7 - $370.96 $605,303 - $767,145	2,068 Added 4.36%	49,449 $18.3 Million
Q3 2020 Nov 12, 2020	SELL	$268.51 - $400.74 $376,451 - $561,837	-1,402 Reduced 2.87%	47,381 $14.6 Million
Q2 2020 Aug 13, 2020	SELL	$256.46 - $373.01 $733,475 - $1.07 Million	-2,860 Reduced 5.54%	48,783 $18.1 Million
Q1 2020 May 14, 2020	BUY	$209.2 - $335.53 $19,455 - $31,204	93 Added 0.18%	51,643 $14.1 Million
Q4 2019 Feb 10, 2020	SELL	$288.29 - $335.49 $81,586 - $94,943	-283 Reduced 0.55%	51,550 $17.1 Million
Q3 2019 Nov 12, 2019	SELL	$266.84 - $378.23 $623,871 - $884,301	-2,338 Reduced 4.32%	51,833 $15.8 Million
Q2 2019 Jul 30, 2019	SELL	$300.59 - $368.15 $397,379 - $486,694	-1,322 Reduced 2.38%	54,171 $19.9 Million
Q1 2019 May 14, 2019	BUY	$272.57 - $321.18 $29,164 - $34,366	107 Added 0.19%	55,493 $17.2 Million
Q4 2018 Feb 12, 2019	SELL	$272.46 - $366.54 $4.2 Million - $5.66 Million	-15,429 Reduced 21.79%	55,386 $16.6 Million
Q3 2018 Nov 13, 2018	SELL	$279.04 - $367.06 $730,805 - $961,330	-2,619 Reduced 3.57%	70,815 $26 Million
Q2 2018 Aug 01, 2018	SELL	$228.17 - $292.07 $154,699 - $198,023	-678 Reduced 0.91%	73,434 $20.5 Million
Q1 2018 May 14, 2018	SELL	$209.54 - $253.91 $1.48 Million - $1.8 Million	-7,079 Reduced 8.72%	74,112 $17.5 Million
Q4 2017 Feb 13, 2018	SELL	$202.23 - $230.03 $2.26 Million - $2.57 Million	-11,153 Reduced 12.08%	81,191 $17.7 Million
Q3 2017 Nov 13, 2017	BUY	$172.3 - $213.93 $161,962 - $201,094	940 Added 1.03%	92,344 $18.4 Million
Q2 2017 Aug 07, 2017	BUY	N/A	91,404	91,404 $15.9 Million

Others Institutions Holding ILMN

# of Institutions

899

Shares Held

137M

Call Options Held

1.22M

Put Options Held

1.43M

View Full List

About ILLUMINA, INC.

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

More about ILMN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

News

Stay updated on Aviva PLC with notifications on news.

Account